Liabilities / Assets
58th percentile
Tied with the lowest-debt nonprofits in its peer group.
Eicosanoid Research Foundation
990 • Fiscal year 2022 • EIN 27-0097769
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
58th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
17th percentile
Higher net margin than 17% of similar nonprofits.
Top Officer Pay
78th percentile
Higher top officer pay than 78% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
5th percentile
Faster asset growth than 5% of similar nonprofits.
Revenue Growth
92nd percentile
Faster revenue growth than 92% of similar nonprofits.
Balance Sheet
Assets
Down$17,889
Down $71,094 (-80%) from 2021
Net Assets
Down$17,889
Down $66,349 (-79%) from 2021
Liabilities
Down$0
Down $4,745 (-100%) from 2021
Revenue And Expenses
Revenue
Up$265,748
Up $186,945 (+237%) from 2021
Expenses
Up$332,097
Up $311,637 (+1523%) from 2021
Net Income
Down-$66,349
Down $124,692 (-214%) from 2021
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2022 to Dec 31, 2022
- Signed
- Nov 15, 2023
- Return Version
- 2022v5.0
- Gross Receipts
- $265,748
Mission and Program Overview
Mission
The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's bi-annual conference. The eicosanoid research foundation sponsors bi-annual conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds.the main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer
The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's biennial conference. The eicosanoid research foundation sponsors biennial conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds. The main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer,
Balance Sheet Detail
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Cash and Non-Interest-Bearing Accounts | $88,983 | $17,889 | ▼ $71,094 |
| Total Assets | $88,983 | $17,889 | ▼ $71,094 |
| Liabilities | |||
| Accounts Payable and Accrued Expenses | $4,745 | - | - |
| Total Liabilities | $4,745 | $0 | ▼ $4,745 |
| Net Assets / Fund Balance | |||
| Net Assets Without Donor Restrictions | $84,238 | $17,889 | ▼ $66,349 |
| Total Net Assets Fund Balance | $84,238 | $17,889 | ▼ $66,349 |
| Total Liabilities and Net Assets / Fund Balance | $88,983 | $17,889 | ▼ $71,094 |
Compensation and Service Providers
Board Members and Trustees
| Name | Title |
|---|---|
| Charles Serhan Phd | Director |
| Edward a Dennis Phd | Director |
| Gabor J Tigyi Md Phd | Director |
| Lawrence J Marnett Phd | Director |
| Makoto Arita Phd | Director |
| Takehiko Yokomizo Md Phd | Director |
Revenue and Support
Revenue Composition
- Contributions and Grants
- $139,190
- Program Service Revenue
- $126,541
- Investment Income
- $17
- Other Revenue
- $0
- Change in Net Assets
- $-66,349
Expenses and Functional Allocation
Major Expense Lines
| Line Item | Amount |
|---|---|
| Other Expenses | $332,097 |
| Grants and Similar Amounts Paid | $0 |
| Professional Fundraising Fees | $0 |
| Salaries, Compensation, and Employee Benefits | $0 |
| Total Fundraising Expense | $0 |
Functional Expense Allocation
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Conferences and Meetings | $204,555 | - | - | $204,555 |
| Travel | $25,431 | - | - | $25,431 |
| All Other Expenses | $8,202 | $6,425 | - | $14,627 |
| Fees for Services Legal | $9,765 | - | - | $9,765 |
| Advertising | $9,034 | - | - | $9,034 |
| Other Expenses | $6,820 | - | - | $6,820 |
| Office Expenses | $4,040 | $1,944 | - | $5,984 |
| Interest | $564 | - | - | $564 |
| Insurance | - | $37 | - | $37 |
| Total Functional Expenses | $323,691 | $8,406 | $0 | $332,097 |
Fundraising, Events, and Gaming
- Fundraising activities
- No
- Gaming activities
- No
- Professional fundraiser used
- No
Fundraising and Gaming Totals
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
Political and Lobbying Activity
- Political campaign activity
- No
- Lobbying activity
- No
- Subject to proxy tax
- No
Governance and Compliance
Governance Checklist
- Compiled or reviewed by an accountant
- No
- Backup withholding compliance
- No
- Business relationship with 35% controlled entity
- No
- Business relationship with family members
- No
- Business relationship with organization members
- No
- Material changes to governing documents
- No
- Compensation from other sources disclosed
- No
- CEO compensation reviewed
- No
- Other officer compensation reviewed
- No
- Conflict-of-interest policy
- No
- Audited financial statements prepared
- No
- Key decisions subject to board approval
- No
- Management duties delegated
- No
Governance Explanations
Form 990, Page 6, Part VI, Line 11B
“No review was or will be conducted”
Form 990, Page 6, Part VI, Line 12C
“Annual completion of conflict of interest and commitment disclosure form”
Form 990, Page 6, Part VI, Line 19
“No other documents available to the public”
Filing and Contact Details
Filer
- Filer Name
- Eicosanoid Research Foundation
- EIN
- 27-0097769
- Phone
- 3135772999
- Address
- 5101 CASS AVENUE 431 CHEMISTRY BLD, DETROIT, MI 48202
Signing Officer
- Name
- Charles Serhan Phd
- Title
- Director
- Phone
- 3135772999
- Signed
- 2023-11-15
- Discuss with paid preparer
- Yes
Organization Details
- Principal Officer
- Charles Serhan Phd
- Formed
- 2004
- Voting Board Members
- 7
- Independent Board Members
- 7
- Employees
- 0
Preparer
- Firm
- Alan C Young & Associates Pc
- Address
- 7310 WOODWARD AVE STE 740, DETROIT, MI 48202
- Preparer
- Anil Sakhuja
- Phone
- 3138737500
Supplemental Narrative
Additional Explanations
FORM 990 - ORGANIZATION'S MISSION
“The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's biennial conference. The eicosanoid research foundation sponsors biennial conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds. The main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer, inflammation and related diseases thereby promoting advances in this area of science and medical research. The foundation also organizes, supports and hosts the annual wayne state university lipids symposium. The symposium addresses the vital roles of lipids in cellular processes required for normal physiological function.”
Form 990, Page 2, Part III, Line 4A
“Biennial bioactive lipids conference: the organization held an informative and successful conference in the fall of 2022 relating to the dissemination of the latest scientific and medical information on bio-active lipids in health and disease, including cancer. This was the 17th international conference scheduled in new orleans, louisiana, usa from october 30 - november 2, 2022. The conference successfully promoted the exchange of ideas and theories in this area among scientists and medical professionals around the world, in an effort to find a cure for diease and the resolutin of imflammatory diseases.”
Raw XML Appendix329 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | false |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 4745 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | false |
| IRS990/ActivityOrMissionDesc | 0 | THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, |
| IRS990/AdvertisingGrp/ProgramServicesAmt | 0 | 9034 |
| IRS990/AdvertisingGrp/TotalAmt | 0 | 9034 |
| IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt | 0 | 6425 |
| IRS990/AllOtherExpensesGrp/ProgramServicesAmt | 0 | 8202 |
| IRS990/AllOtherExpensesGrp/TotalAmt | 0 | 14627 |
| IRS990/BackupWthldComplianceInd | 0 | false |
| IRS990/BooksInCareOfDetail/PersonNm | 0 | CHARLES SERHAN PHD |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 3135772999 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 5101 CASS AVENUE 431 CHEMISTRY BLD |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | DETROIT |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | MI |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 48202 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | false |
| IRS990/BusinessRlnWithFamMemInd | 0 | false |
| IRS990/BusinessRlnWithOrgMemInd | 0 | false |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 88983 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 17889 |
| IRS990/ChangeToOrgDocumentsInd | 0 | false |
| IRS990/CollectionsOfArtInd | 0 | false |
| IRS990/CompensationFromOtherSrcsInd | 0 | false |
| IRS990/CompensationProcessCEOInd | 0 | false |
| IRS990/CompensationProcessOtherInd | 0 | false |
| IRS990/ConferencesMeetingsGrp/ProgramServicesAmt | 0 | 204555 |
| IRS990/ConferencesMeetingsGrp/TotalAmt | 0 | 204555 |
| IRS990/ConflictOfInterestPolicyInd | 0 | false |
| IRS990/ConservationEasementsInd | 0 | false |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | false |
| IRS990/CreditCounselingInd | 0 | false |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 139190 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 0 |
| IRS990/CYInvestmentIncomeAmt | 0 | 17 |
| IRS990/CYOtherExpensesAmt | 0 | 332097 |
| IRS990/CYOtherRevenueAmt | 0 | 0 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 126541 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | -66349 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 0 |
| IRS990/CYTotalExpensesAmt | 0 | 332097 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 0 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 265748 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | false |
| IRS990/DeductibleArtContributionInd | 0 | false |
| IRS990/DeductibleNonCashContriInd | 0 | false |
| IRS990/DelegationOfMgmtDutiesInd | 0 | false |
| IRS990/Desc | 0 | BIENNIAL BIOACTIVE LIPIDS CONFERENCE: THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2022 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIO-ACTIVE LIPIDS IN HEALTH AND DISEASE, INCLUDING CANCER. THIS WAS THE 17TH INTERNATIONAL CONFERENCE SCHEDULED IN NEW ORLEANS, LOUISIANA, USA FROM OCTOBER 30 - NOVEMBER 2, 2022. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMONG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR DIEASE AND THE RESOLUTIN OF IMFLAMMATORY DISEASES. |
| IRS990/DescribedInSection501c3Ind | 0 | true |
| IRS990/DisregardedEntityInd | 0 | false |
| IRS990/DocumentRetentionPolicyInd | 0 | false |
| IRS990/DonorAdvisedFundInd | 0 | false |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | false |
| IRS990/ElectionOfBoardMembersInd | 0 | false |
| IRS990/EmployeeCnt | 0 | 0 |
| IRS990/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990/ExpenseAmt | 0 | 323691 |
| IRS990/FamilyOrBusinessRlnInd | 0 | false |
| IRS990/FeesForServicesLegalGrp/ProgramServicesAmt | 0 | 9765 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 9765 |
| IRS990/ForeignActivitiesInd | 0 | false |
| IRS990/ForeignFinancialAccountInd | 0 | false |
| IRS990/ForeignOfficeInd | 0 | false |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 3.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 3 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 4 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 5 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 5 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | EDWARD A DENNIS PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | LAWRENCE J MARNETT PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | CHARLES SERHAN PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 3 | GABOR J TIGYI MD PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 4 | MAKOTO ARITA PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 5 | TAKEHIKO YOKOMIZO MD PHD |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 3 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 4 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 5 | DIRECTOR |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | false |
| IRS990/FormationYr | 0 | 2004 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | false |
| IRS990/FSAuditedInd | 0 | false |
| IRS990/FundraisingActivitiesInd | 0 | false |
| IRS990/GamingActivitiesInd | 0 | false |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 7 |
| IRS990/GovernmentGrantsAmt | 0 | 139190 |
| IRS990/GrantsToIndividualsInd | 0 | false |
| IRS990/GrantsToOrganizationsInd | 0 | false |
| IRS990/GrantToRelatedPersonInd | 0 | false |
| IRS990/GrossReceiptsAmt | 0 | 265748 |
| IRS990/GroupReturnForAffiliatesInd | 0 | false |
| IRS990/IncludeFIN48FootnoteInd | 0 | false |
| IRS990/IndependentAuditFinclStmtInd | 0 | false |
| IRS990/IndependentVotingMemberCnt | 0 | 7 |
| IRS990/IndoorTanningServicesInd | 0 | false |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InsuranceGrp/ManagementAndGeneralAmt | 0 | 37 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 37 |
| IRS990/InterestGrp/ProgramServicesAmt | 0 | 564 |
| IRS990/InterestGrp/TotalAmt | 0 | 564 |
| IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt | 0 | 17 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 17 |
| IRS990/InvestmentInJointVentureInd | 0 | false |
| IRS990/IRPDocumentCnt | 0 | 0 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LoanOutstandingInd | 0 | false |
| IRS990/LobbyingActivitiesInd | 0 | false |
| IRS990/LocalChaptersInd | 0 | false |
| IRS990/MaterialDiversionOrMisuseInd | 0 | false |
| IRS990/MembersOrStockholdersInd | 0 | false |
| IRS990/MethodOfAccountingCashInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | true |
| IRS990/MinutesOfGoverningBodyInd | 0 | true |
| IRS990/MissionDesc | 0 | THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, |
| IRS990/MoreThan5000KToIndividualsInd | 0 | false |
| IRS990/MoreThan5000KToOrgInd | 0 | false |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 84238 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 17889 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 84238 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 17889 |
| IRS990/NoListedPersonsCompensatedInd | 0 | X |
| IRS990/NondeductibleContributionsInd | 0 | false |
| IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt | 0 | 1944 |
| IRS990/OfficeExpensesGrp/ProgramServicesAmt | 0 | 4040 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 5984 |
| IRS990/OfficerMailingAddressInd | 0 | false |
| IRS990/OperateHospitalInd | 0 | false |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherExpensesGrp/Desc | 0 | POSTER AWARDS |
| IRS990/OtherExpensesGrp/Desc | 1 | CONTRACTORS |
| IRS990/OtherExpensesGrp/Desc | 2 | PROMOTIONS |
| IRS990/OtherExpensesGrp/Desc | 3 | SPEAKER GIFTS |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 24750 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 1 | 22880 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 2 | 7650 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 3 | 6820 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 24750 |
| IRS990/OtherExpensesGrp/TotalAmt | 1 | 22880 |
| IRS990/OtherExpensesGrp/TotalAmt | 2 | 7650 |
| IRS990/OtherExpensesGrp/TotalAmt | 3 | 6820 |
| IRS990/PartialLiquidationInd | 0 | false |
| IRS990/PoliticalCampaignActyInd | 0 | false |
| IRS990/PrincipalOfficerNm | 0 | CHARLES SERHAN PHD |
| IRS990/ProfessionalFundraisingInd | 0 | false |
| IRS990/ProgramServiceRevenueGrp/Desc | 0 | REGISTRATION |
| IRS990/ProgramServiceRevenueGrp/Desc | 1 | EXHABITOR FEES |
| IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 123607 |
| IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt | 1 | 2934 |
| IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt | 0 | 123607 |
| IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt | 1 | 2934 |
| IRS990/ProgSrvcAccomActy2Grp/Desc | 0 | ANNUAL WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM: THE WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM ADDRESSES THE VITAL ROLES OF LIPIDS IN CELLULAR PROCESSES REQUIRED FOR NORMAL PHYSIOLOGICAL FUNCTION. THE 7TH WSU LIPIDS SYMPOSIUM WAS SCHEDULED FOR MAY 13, 2020 IN THE STUDENT BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY. DUE TO THE COVID-19 PANDEMIC, THE EVENT WAS CANCELED. THE SYMPOSIUM HAS BEEN SUSPENDED SINCE THAT POINT, BUT IS CURRENTLY EXPECTED TO RESUME IN EITHER 2023 OR 2024. PREVIOUSLY, THE (6TH) WSU LIPIDS SYMPOSIUM WAS HELD IN THE STUDENT CENTER BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY ON MAY 7, 2019 AND WAS WELL ATTENDED. |
| IRS990/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990/PYExcessBenefitTransInd | 0 | false |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | -66349 |
| IRS990/RelatedEntityInd | 0 | false |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990/ReportInvestmentsOtherSecInd | 0 | false |
| IRS990/ReportLandBuildingEquipmentInd | 0 | false |
| IRS990/ReportOtherAssetsInd | 0 | false |
| IRS990/ReportOtherLiabilitiesInd | 0 | false |
| IRS990/ReportProgramRelatedInvstInd | 0 | false |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 139190 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 72875 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 5000 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 95299 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 28450 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 340814 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt | 0 | 3 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 3 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 17 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 13 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt | 0 | 36 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 126558 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 5925 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 165715 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 298198 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt | 0 | 3 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt | 0 | 3 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt | 0 | 17 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt | 0 | 13 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt | 0 | 36 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.00000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.99990 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.99990 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 639012 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 265748 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 78800 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 5000 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 261014 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 28450 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 639012 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 265748 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 78803 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 5003 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 261031 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 28463 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 639048 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990/ScheduleBRequiredInd | 0 | true |
| IRS990/ScheduleJRequiredInd | 0 | false |
| IRS990/ScheduleORequiredInd | 0 | true |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES THEREBY PROMOTING ADVANCES IN THIS AREA OF SCIENCE AND MEDICAL RESEARCH. THE FOUNDATION ALSO ORGANIZES, SUPPORTS AND HOSTS THE ANNUAL WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM. THE SYMPOSIUM ADDRESSES THE VITAL ROLES OF LIPIDS IN CELLULAR PROCESSES REQUIRED FOR NORMAL PHYSIOLOGICAL FUNCTION. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | BIENNIAL BIOACTIVE LIPIDS CONFERENCE: THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2022 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIO-ACTIVE LIPIDS IN HEALTH AND DISEASE, INCLUDING CANCER. THIS WAS THE 17TH INTERNATIONAL CONFERENCE SCHEDULED IN NEW ORLEANS, LOUISIANA, USA FROM OCTOBER 30 - NOVEMBER 2, 2022. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMONG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR DIEASE AND THE RESOLUTIN OF IMFLAMMATORY DISEASES. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | NO REVIEW WAS OR WILL BE CONDUCTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | ANNUAL COMPLETION OF CONFLICT OF INTEREST AND COMMITMENT DISCLOSURE FORM |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | NO OTHER DOCUMENTS AVAILABLE TO THE PUBLIC |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990 - ORGANIZATION'S MISSION |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990, PAGE 2, PART III, LINE 4A |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990, PAGE 6, PART VI, LINE 11B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990, PAGE 6, PART VI, LINE 12C |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990, PAGE 6, PART VI, LINE 19 |
| IRS990/SchoolOperatingInd | 0 | false |
| IRS990/SignificantChangeInd | 0 | false |
| IRS990/SignificantNewProgramSrvcInd | 0 | false |
| IRS990/SubjectToExcsTaxNetInvstIncInd | 0 | false |
| IRS990/SubjectToProxyTaxInd | 0 | false |
| IRS990/SubjToTaxRmnrtnExPrchtPymtInd | 0 | false |
| IRS990/TaxablePartyNotificationInd | 0 | false |
| IRS990/TaxExemptBondsInd | 0 | false |
| IRS990/TerminateOperationsInd | 0 | false |
| IRS990/TotalAssetsBOYAmt | 0 | 88983 |
| IRS990/TotalAssetsEOYAmt | 0 | 17889 |
| IRS990/TotalAssetsGrp/BOYAmt | 0 | 88983 |
| IRS990/TotalAssetsGrp/EOYAmt | 0 | 17889 |
| IRS990/TotalCompGreaterThan150KInd | 0 | false |
| IRS990/TotalContributionsAmt | 0 | 139190 |
| IRS990/TotalEmployeeCnt | 0 | 0 |
| IRS990/TotalFunctionalExpensesGrp/FundraisingAmt | 0 | 0 |
| IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt | 0 | 8406 |
| IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt | 0 | 323691 |
| IRS990/TotalFunctionalExpensesGrp/TotalAmt | 0 | 332097 |
| IRS990/TotalGrossUBIAmt | 0 | 0 |
| IRS990/TotalLiabilitiesBOYAmt | 0 | 4745 |
| IRS990/TotalLiabilitiesEOYAmt | 0 | 0 |
| IRS990/TotalLiabilitiesGrp/BOYAmt | 0 | 4745 |
| IRS990/TotalLiabilitiesGrp/EOYAmt | 0 | 0 |
| IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt | 0 | 84238 |
| IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt | 0 | 17889 |
| IRS990/TotalProgramServiceExpensesAmt | 0 | 323691 |
| IRS990/TotalProgramServiceRevenueAmt | 0 | 126541 |
| IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 126558 |
| IRS990/TotalRevenueGrp/TotalRevenueColumnAmt | 0 | 265748 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt | 0 | 88983 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt | 0 | 17889 |
| IRS990/TravelGrp/ProgramServicesAmt | 0 | 25431 |
| IRS990/TravelGrp/TotalAmt | 0 | 25431 |
| IRS990/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990/TypeOfOrganizationCorpInd | 0 | X |
| IRS990/UnrelatedBusIncmOverLimitInd | 0 | false |
| IRS990/USAddress/AddressLine1Txt | 0 | 5101 CASS AVENUE 431 CHEMISTRY BLD |
| IRS990/USAddress/CityNm | 0 | DETROIT |
| IRS990/USAddress/StateAbbreviationCd | 0 | MI |
| IRS990/USAddress/ZIPCd | 0 | 48202 |
| IRS990/VotingMembersGoverningBodyCnt | 0 | 7 |
| IRS990/VotingMembersIndependentCnt | 0 | 7 |
| IRS990/WebsiteAddressTxt | 0 | WWW.EICOSANOIDRESEARCHFOUNDATION.ORG |
| IRS990/WhistleblowerPolicyInd | 0 | false |
| ReturnHeader/BuildTS | 0 | 2023-04-26 12:10:37Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | CHARLES SERHAN PHD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | DIRECTOR |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 3135772999 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2023-11-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | EICOSANOID RESEARCH FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | EICO |
| ReturnHeader/Filer/EIN | 0 | 270097769 |
| ReturnHeader/Filer/PhoneNum | 0 | 3135772999 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 5101 CASS AVENUE 431 CHEMISTRY BLD |
| ReturnHeader/Filer/USAddress/CityNm | 0 | DETROIT |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | MI |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 48202 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | false |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 382463166 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | ALAN C YOUNG & ASSOCIATES PC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 7310 WOODWARD AVE STE 740 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | DETROIT |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | MI |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 48202 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 3138737500 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2023-11-15 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | ANIL SAKHUJA |
| ReturnHeader/ReturnTs | 0 | 2023-11-15T17:42:56-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990 |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | CHARLES |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | SERHAN |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2022-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2022-12-31 |
| ReturnHeader/TaxYr | 0 | 2022 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2022 • Form 990Detailed filing. Detailed filing data is available for this year.
- Assets
- $17,889
- Liabilities
- $0
- Net assets
- $17,889
- Revenue
- $265,748
- Expenses
- $332,097
- Net income
- -$66,349